Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine mechanisms of insulin resistance in healthy volunteers
NCT02708394Phase 1Completed
- Sponsor
- Wayne State University
- Start
- Feb 2017
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in schizophrenia comparing Olanzapine with Placebo (2 arms). Primary endpoint: Change in DNA methylation at 7 days. Started Feb 2017; status: completed.
02
Drugs
olanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02708394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02708394.